Activation of Shc1 Allows Oncostatin M to Induce RANKL and Osteoclast Formation More Effectively Than Leukemia Inhibitory Factor
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.01164
Full Text
Open PDFAbstract
Available in full text
Date
May 28, 2019
Authors
Publisher
Frontiers Media SA